StepStone Group’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-522,987
Closed -$18.8M – 26
2022
Q4
$18.8M Hold
522,987
– – 2.47% 7
2022
Q3
$7.87M Hold
522,987
– – 1.12% 14
2022
Q2
$7M Hold
522,987
– – 0.75% 17
2022
Q1
$10.1M Hold
522,987
– – 0.75% 13
2021
Q4
$12.4M Hold
522,987
– – 0.71% 14
2021
Q3
$8.37M Buy
+522,987
New +$11.2M 0.54% 14

StepStone Group's IMGO Position: Q1 2023 in Review

StepStone Group sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 522,987 shares — an estimated $18.8M sold.

StepStone Group first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $18.8M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • StepStone Group reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • StepStone Group sold 522,987 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $18.8M.
  • StepStone Group first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
  • StepStone Group's Imago BioSciences, Inc. Common stock position peaked at $18.8M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on StepStone Group's 13F filing for Q1 2023, filed 15 May 2023.